| Obesity as risk factor for lactic acidosis during nucleoside analogue treatment. | |
| | |
MedLine Citation:
|
PMID: 20229521 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Akif Altinbas; Fuat Ekiz; Osman Yuksel |
Publication Detail:
|
Type: Comment; Letter |
Journal Detail:
|
Title: Hepatology (Baltimore, Md.) Volume: 51 ISSN: 1527-3350 ISO Abbreviation: Hepatology Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-31 Completed Date: 2010-06-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8302946 Medline TA: Hepatology Country: United States |
Other Details:
|
Languages: eng Pagination: 2235 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acidosis, Lactic
/
chemically induced*,
complications Humans Nucleosides / adverse effects* Obesity / complications* Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Nucleosides |
| Comments/Corrections | |
Comment On:
|
Hepatology. 2009 Dec;50(6):2001-6
[PMID:
19937695
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Test of a conceptual model of uncertainty in children and adolescents with cancer.
Next Document: In vivo testing of a biodegradable woven fabric made of bioactive glass fibers and PLGA(80)-A pilot ...